TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 65 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,036,000 | +81.0% | 628,500 | 0.0% | 0.23% | +93.3% |
| Q2 2021 | $6,096,000 | -8.6% | 628,500 | +1.2% | 0.12% | -17.2% |
| Q1 2021 | $6,667,000 | -26.7% | 620,800 | +0.4% | 0.14% | -24.9% |
| Q4 2020 | $9,098,000 | -17.0% | 618,500 | -19.8% | 0.19% | -30.6% |
| Q3 2020 | $10,955,000 | +77.6% | 770,918 | +1.1% | 0.28% | +64.5% |
| Q2 2020 | $6,170,000 | +103.6% | 762,618 | +1.7% | 0.17% | +35.2% |
| Q1 2020 | $3,030,000 | – | 750,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 206,800 | $36,314,000 | 8.27% |
| Fairmount Funds Management LLC | 886,281 | $15,563,000 | 5.66% |
| FRAZIER MANAGEMENT LLC | 3,123,107 | $54,984,000 | 4.40% |
| ACT CAPITAL MANAGEMENT, LLC | 466,000 | $8,183,000 | 4.24% |
| RAMIUS ADVISORS LLC | 338,042 | $5,936,000 | 3.54% |
| Western Standard LLC | 265,355 | $4,660,000 | 2.65% |
| HAVENS ADVISORS LLC | 109,000 | $1,914,000 | 2.30% |
| Crabel Capital Management, LLC | 423,490 | $7,436,000 | 2.29% |
| S. MUOIO & CO. LLC | 160,000 | $2,810,000 | 2.16% |
| Omni Partners US LLC | 2,366,824 | $41,561,000 | 2.13% |